PHIO PHARMACEUTICALS CORP's ticker is PHIOW and the CUSIP is 71880W105. A total of 3 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | -100.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | – | 3,000 | -18.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 3,700 | +23.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 3,000 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 434,046 | $164,000 | 0.04% |
| UBS Group AG | 3,578 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 150,669 | $6,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3,000 | $0 | 0.00% |